Trials / Completed
CompletedNCT01623479
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 585 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost 0.03% | Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months |
Timeline
- Start date
- 2010-11-19
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2012-06-20
- Last updated
- 2019-04-16
- Results posted
- 2012-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01623479. Inclusion in this directory is not an endorsement.